Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,154B 12.31B 10.99B 10.11B 9.18B 17.39B 17.82B 121B 48.21B 618B 46.2B 45.21B 1,946B P/E 2027 *
31.5x
P/E 2028 * 23.7x
Enterprise Value 1,123B 11.99B 10.7B 9.84B 8.93B 16.93B 17.35B 118B 46.94B 601B 44.99B 44.03B 1,894B EV / Sales 2027 *
3.2x
EV / Sales 2028 * 2.81x
Free-Float
68.54%
Yield 2027 *
0.54%
Yield 2028 * 0.6%
1 day+1.01%
1 week+3.34%
Current month+2.58%
1 month+15.89%
3 months+18.17%
6 months+7.09%
Current year+8.97%
1 week 1,346.45
Extreme 1346.45
1,390
1 month 1,195.65
Extreme 1195.65
1,390.7
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Date Insider Type Main position Quantity % Market Cap. Importance
4/1/26 Other

Global Head of Quality and PV

35,600 0.0043% -
12/18/25 Other

Chairman

85,738,125 10.2732%
12/18/25 Other

Director

12,717,090 1.5238%
Change 5-day change 1-year change 3-year change Capi.($)
+1.01%+3.34%+14.91%+27.00% 12.31B
+4.28%+0.07%+52.75%+138.78% 1,258B
+2.13%+4.27%+51.21%+91.36% 679B
+0.68%+1.54%+33.83%+112.47% 518B
+2.77%+0.98%+49.44%+68.46% 390B
+1.38%+0.27%+72.42%+45.30% 367B
+0.29%+1.48%+30.84%+58.32% 307B
+0.98%+1.49%+9.04%+34.78% 293B
+1.04%-0.05%+45.29%+76.18% 252B
+1.46%-0.59%+42.48%+125.82% 210B
Average +1.64%+1.28%+40.22%+77.85% 429B
Weighted average by Cap. +2.31%+1.18%+45.99%+96.19%

Financials

2027 *2028 *
Net sales 351B 3.75B 3.35B 3.08B 2.79B 5.29B 5.43B 36.82B 14.68B 188B 14.07B 13.77B 592B 393B 4.19B 3.74B 3.45B 3.13B 5.93B 6.07B 41.21B 16.43B 210B 15.74B 15.41B 663B
Net income 36.5B 389M 348M 320M 290M 550M 564M 3.83B 1.52B 19.54B 1.46B 1.43B 61.54B 49.21B 525M 469M 431M 391M 742M 760M 5.16B 2.06B 26.34B 1.97B 1.93B 82.97B
Net Debt -30.34B -324M -289M -266M -241M -457M -469M -3.18B -1.27B -16.24B -1.22B -1.19B -51.16B -49.26B -525M -469M -432M -392M -742M -761M -5.16B -2.06B -26.37B -1.97B -1.93B -83.05B
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
26-11-09 ₹1,385.00 +1.17% 74,169
26-11-08 ₹1,369.00 -0.16% 8,599
26-11-06 ₹1,371.20 +0.76% 94,059
26-11-05 ₹1,360.80 -0.82% 28,482
26-11-04 ₹1,372.00 +0.15% 47,144
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,385.00INR
Average target price
1,358.95INR
Spread / Average Target
-1.88%
  1. Stock Market
  2. Stocks
  3. DRREDDY Stock